MLP Sağlık Hizmetleri (MPARK) Fundamental Analysis
This page summarises the financial statements and the KapAI scorecard of MLP Sağlık Hizmetleri (MPARK) in the İlaç ve Sağlık sector for the 2026/6 period. Figures are compiled from the company’s reported balance sheet and income statement, in millions of Turkish lira.
Company Information
- Company: MLP Sağlık Hizmetleri
- Ticker: MPARK
- Sector: İlaç ve Sağlık
- Latest reporting period: 2026/6
KapAI Scorecard
Overall score: 2.8 / 5
- Profitability: 4.0 / 5
- Liquidity: 1.5 / 5
- Leverage: 2.1 / 5
- Efficiency: 3.4 / 5
Summary Income Statement (TRY million)
Period: 2026/6 · Compared with: 2025/6
| Item | 2026/6 | 2025/6 | Change |
|---|---|---|---|
| Revenue | 34,127 | 32,144 | +6.2% |
| Gross Profit | 8,930 | 8,561 | +4.3% |
| Operating Profit | 5,201 | 5,915 | -12.1% |
| EBITDA | 0 | 0 | — |
| Net Monetary Position Gains | 2,172 | 1,563 | +39.0% |
| Net Profit for the Period | 3,543 | 3,285 | +7.9% |
Summary Balance Sheet (TRY million)
Period: 2026/6 · Compared with: 2025/6
| Item | 2026/6 | 2025/6 | Change |
|---|---|---|---|
| Current Assets | 23,348 | 19,298 | +21.0% |
| Non-Current Assets | 71,956 | 46,545 | +54.6% |
| Total Assets | 95,304 | 65,843 | +44.7% |
| Current Liabilities | 27,824 | 12,334 | +125.6% |
| Non-Current Liabilities | 21,101 | 23,775 | -11.2% |
| Total Liabilities | 48,925 | 36,109 | +35.5% |